BAP1- or PTEN-mutated ccRCCs showed significantly higher CD8 + TIL counts at the invasive margin and at the tumor periphery in comparison to other ccRCCs (p = 0.03; Table 2). This evidence concerns the gene BAP1 and neoplasm.